Summary
This prediction ended on 14.12.24 with a price of €180.35. The BUY prediction by BiotechBee finished with a performance of 12.05%. BiotechBee has 80% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| UCB S.A. | -7.297% | -7.297% | 62.230% |
| iShares Core DAX® | -1.741% | 5.979% | 8.977% |
| iShares Nasdaq 100 | 2.815% | 11.827% | 38.406% |
| iShares Nikkei 225® | -0.109% | 11.692% | 46.680% |
| iShares S&P 500 | 0.966% | 7.616% | 28.141% |
According to BiotechBee what are the pros and cons of UCB S.A. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread UCB S.A. diskutieren
Buy mit Kursziel 210,0